Given that obesity-related increase in NLRP3 inflammasome activation is a predominant regulator of IL-1β production and decreased health span (45-47), we next tested whether SPARC gain of function impacts the inflammasome. The gene discussed is SPARC; the disease is obesity due to melanocortin 4 receptor deficiency.